Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Frisoni

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Neurobiology of Aging|November 19, 2019
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neuronsClaudio Babiloni, Katarzyna Blinowska, Laura Bonanni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2020
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementiaCarolin Heller, Martha S Foiani, Katrina Moore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
Plos Medicine|September 25, 2018
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trialBrian Lawlor, Ricardo Segurado, Sean Kennelly, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2012
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitMary D Naylor, Jason H Karlawish, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Neurobiology of Aging|November 19, 2019
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neuronsClaudio Babiloni, Katarzyna Blinowska, Laura Bonanni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2020
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementiaCarolin Heller, Martha S Foiani, Katrina Moore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
Plos Medicine|September 25, 2018
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trialBrian Lawlor, Ricardo Segurado, Sean Kennelly, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2012
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitMary D Naylor, Jason H Karlawish, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Pageof 9